ARTICLE | Clinical News
Allob: Completed Phase IIa enrollment
May 9, 2016 7:00 AM UTC
Bone Therapeutics completed enrollment of 18 patients in an open-label, Belgian Phase IIa trial evaluating a single implantation of Allob mixed with bioceramic granules. The study enrolled patients wi...